Carcinogenicity Study of Bupropion

CompletedOBSERVATIONAL
Enrollment

50,430

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Depressive DisorderCancer
Interventions
DRUG

Regular bupropion use

Regular use of bupropion is defined as use at least 4 times per week for at least 3 continuous months at least 12 months before index date.

DRUG

Regular SSRI (Selective serotonin reuptake inhibitors) use

Regular use of SSRI is defined as use at least 4 times per week for at least 3 continuous months at least 12 months before index date.

DRUG

Regular TCA (Tricyclic antidepressants) use

Regular use of TCA is defined as use at least 4 times per week for at least 3 continuous months at least 12 months before index date.

DRUG

Regular use of any other antidepressant

"Regular use of any other antidepressants is defined as use at least 4 times per week for at least 3 continuous months at least 12 months before index date. An other antidepressant would be any antidepressant other than bupropion, a SSRI or a TCA."

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01077596 - Carcinogenicity Study of Bupropion | Biotech Hunter | Biotech Hunter